GlaxoSmithKline - Raxibacumab - Ownership and Business Overview

Healthcare ServicesCompany

GlaxoSmithKline - Raxibacumab Ownership

Who owns GlaxoSmithKline - Raxibacumab?

GlaxoSmithKline - Raxibacumab is owned by Emergent BioSolutions. It was acquired on July 19, 2017.

GlaxoSmithKline - Raxibacumab Business Overview

Where is GlaxoSmithKline - Raxibacumab headquartered?

GlaxoSmithKline - Raxibacumab is headquartered in Brentford, United Kingdom.

What sector is GlaxoSmithKline - Raxibacumab in?

GlaxoSmithKline - Raxibacumab is a healthcare services company.

Healthcare Services M&A Summary in 2017

Out of 60 sectors in the Mergr database, healthcare services ranked 5 in number of deals in 2017. The largest healthcare services acquisition in 2017 was Kindred Healthcare - which was acquired by TPG for $4.1B.

Join Mergr to view all 371 acquisitions of healthcare services companies in 2017, including 75 acquisitions by private equity firms, and 296 by strategics.

GlaxoSmithKline plc - Raxibacumab

Brentford, TW8 9GS
United Kingdom,

GlaxoSmithKline plc - Raxibacumab is an indicated for the treatment of adult and pediatric patients with inhalational anthrax in combination with appropriate antibacterial drugs and for prophylaxis of inhalational anthrax when alternative therapies are not available or not appropriate.


 Subscribe to unlock this and 206,758
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for GlaxoSmithKline - Raxibacumab

Healthcare Services Companies , United Kingdom Companies